| A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma (NCT03126591) | Eli Lilly and Company | 2017-07-03 |
| Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma (NCT03168061) | NanoCarrier Co., Ltd. | 2017-06-30 |
| Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NCT03116529) | University of Maryland, Baltimore | 2017-06-21 |
| Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (NCT03277924) | Grupo Espanol de Investigacion en Sarcomas | 2017-05-31 |
| Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study (NCT03546127) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-05-23 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas (NCT03042819) | University Health Network, Toronto | 2017-05-16 |
| Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. (NCT03085225) | Institut Bergonié | 2017-05-05 |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (NCT03242382) | Grupo Espanol de Investigacion en Sarcomas | 2017-03-31 |
| A Phase II Study of Apatinib in STS Patients (NCT03064243) | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 2017-03-01 |
| A Study Evaluating MM-310 in Patients With Solid Tumors (NCT03076372) | Merrimack Pharmaceuticals | 2017-02-22 |
| Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas (NCT02987959) | Fox Chase Cancer Center | 2017-02-21 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors (NCT02581384) | Dana-Farber Cancer Institute | 2017-01-01 |
| A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors (NCT02784795) | Eli Lilly and Company | 2016-11-04 |
| Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-25 |
| A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma (NCT02783599) | Eli Lilly and Company | 2016-10-11 |
| Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides (NCT02890368) | Pfizer | 2016-09-01 |
| Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma (NCT04055753) | Fox Chase Cancer Center | 2016-08-12 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (NCT02624388) | University of Virginia | 2016-08-01 |
| A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma (NCT03096912) | Assaf-Harofeh Medical Center | 2016-07-01 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma (NCT02571829) | Hadassah Medical Organization | 2016-05-01 |
| A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (NCT02659020) | Eli Lilly and Company | 2016-03-01 |
| Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall (NCT02634710) | Medical College of Wisconsin | 2016-02-23 |
| Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma (NCT02584309) | Washington University School of Medicine | 2016-02-22 |
| In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma (NCT02811523) | University Health Network, Toronto | 2016-02-01 |
| A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (NCT02787642) | Institut Bergonié | 2016-01-01 |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (NCT02630368) | Institut Bergonié | 2015-09-18 |
| A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma (NCT02451943) | Eli Lilly and Company | 2015-09-14 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors (NCT02192333) | Fred Hutchinson Cancer Center | 2015-08-03 |
| Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma (NCT02367924) | PharmaMar, Spain | 2015-07-16 |
| TVEC and Preop Radiation for Sarcoma (4 ml Dose) (NCT02453191) | University of Iowa | 2015-07-13 |
| Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery (NCT02527304) | Albert Einstein College of Medicine | 2015-06-01 |
| Stereotactic Radiosurgery for Soft Tissue Sarcoma (NCT02706171) | The Cooper Health System | 2015-06-01 |
| Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) (NCT02449343) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-05-12 |
| Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy (NCT02300545) | Washington University School of Medicine | 2015-04-08 |
| National Swiss Sarcoma Cohort Study (NCT02775799) | Balgrist University Hospital | 2015-04-01 |
| SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas (NCT02301039) | Sarcoma Alliance for Research through Collaboration | 2015-03-01 |
| Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas (NCT02547376) | University Hospitals, Leicester | 2015-02-12 |
| Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma (NCT02672527) | Gustave Roussy, Cancer Campus, Grand Paris | 2015-01-22 |
| Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma (NCT02267083) | Gem Pharmaceuticals | 2015-01-07 |
| A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma (NCT02255110) | Merck KGaA, Darmstadt, Germany | 2014-12-10 |
| Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma (NCT02204111) | GWT-TUD GmbH | 2014-09-01 |
| Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) (NCT02398058) | Italian Sarcoma Group | 2014-07-20 |
| Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease (NCT02080897) | Duke University | 2014-03-01 |
| Hyperthermia and Proton Therapy in Unresectable Soft Tissue Sarcoma (NCT01904565) | Kantonsspital Aarau | 2014-02-01 |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma (NCT01803152) | Macarena De La Fuente, MD | 2014-01-06 |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer (NCT01896778) | Roswell Park Cancer Institute | 2013-10-04 |
| Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors (NCT01807468) | Samsung Medical Center | 2013-05-01 |
| A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall (NCT01819831) | Loma Linda University | 2013-02-27 |
| Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas (NCT01802125) | Children's Oncology Group | 2013-02-01 |
| Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma (NCT01719744) | University Health Network, Toronto | 2013-01-01 |
| Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma (NCT01812018) | Peng Yuan | 2012-11-01 |
| A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma (NCT01861951) | Hannover Medical School | 2012-10-01 |
| Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria (NCT01650077) | Centre Oscar Lambret | 2012-09-21 |
| Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas (NCT01663090) | Dana-Farber Cancer Institute | 2012-09-01 |
| Cathepsin Activatable Fluorescent Probe (NCT01626066) | David Kirsch | 2012-06-01 |
| Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma (NCT01612481) | Centre Oscar Lambret | 2012-04-02 |
| Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma (NCT01498835) | Heidelberg University | 2012-02-01 |
| An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217) (NCT01458249) | Eisai Co., Ltd. | 2011-11-01 |
| Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569) | Masonic Cancer Center, University of Minnesota | 2011-10-20 |
| Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma (NCT01438554) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-10-01 |
| A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma (NCT01440088) | Threshold Pharmaceuticals | 2011-09-01 |
| Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma (NCT01259375) | University of Utah | 2011-09-01 |
| Evaluating Bacterial Response in Sarcoma Management Using Fluorescence Imaging (NCT02270086) | University Health Network, Toronto | 2011-08-01 |
| High Precision RT For Soft-Tissue Sarcoma (NCT01389050) | University Health Network, Toronto | 2011-06-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma (NCT01327885) | Eisai Inc. | 2011-03-10 |
| Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma (NCT01303094) | Centre Oscar Lambret | 2011-02-01 |
| Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma (NCT01296659) | The University of Texas Health Science Center at San Antonio | 2011-02-01 |
| Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) (NCT01347034) | H. Lee Moffitt Cancer Center and Research Institute | 2011-01-01 |
| Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide (NCT01299506) | PharmaMar | 2010-12-01 |
| Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology (NCT01696760) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas (NCT01106872) | Mohammed M Milhem | 2010-09-01 |
| A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas (NCT01140737) | Sheffield Teaching Hospitals NHS Foundation Trust | 2010-08-31 |
| Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma (NCT01168791) | Alaunos Therapeutics | 2010-07-01 |
| Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden (NCT01136824) | University of Pittsburgh | 2010-06-01 |
| Pharmacokinetic Study of Doxorubicin in Children With Cancer (NCT01095926) | University Hospital Muenster | 2010-05-01 |
| Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS) (NCT00918489) | Heidelberg University | 2010-05-01 |
| HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors (NCT00931931) | Timothy Cripe | 2010-03-01 |
| Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection (NCT01575951) | University of Utah | 2010-02-01 |
| Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma (NCT01055028) | Stanford University | 2010-02-01 |
| Identification and Characterization of Molecular Markers in Musculoskeletal Tumors (NCT02199938) | Balgrist University Hospital | 2010-01-01 |
| Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure (NCT01136499) | Centre Leon Berard | 2010-01-01 |
| Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers (NCT01005797) | Medical University of South Carolina | 2009-11-01 |
| Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma (NCT00876031) | University Hospital Tuebingen | 2009-07-01 |
| Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas (NCT00998361) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2009-06-01 |
| Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall (NCT00864032) | University of California, Davis | 2009-03-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Phase II Study of Doxorubicin and Avastin® in Sarcoma. (NCT00755261) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-09-01 |
| Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma (NCT00753727) | Australasian Sarcoma Study Group | 2008-09-01 |
| Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma (NCT00717522) | Celgene | 2008-08-01 |
| Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma (NCT00742963) | ImmunoGenesis | 2008-08-01 |
| A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma (NCT00718484) | Alaunos Therapeutics | 2008-08-01 |
| Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types (NCT00633789) | Bristol-Myers Squibb | 2008-06-01 |
| Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma (NCT01102608) | Grupo Espanol de Investigacion en Sarcomas | 2008-03-01 |
| Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma (NCT00626704) | Amgen | 2007-11-01 |
| Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma (NCT00541840) | Grupo Espanol de Investigacion en Sarcomas | 2007-10-01 |